Alteration by prolonged oral administration of a thyrotropin-releasing hormone analog, ta-0910, of the pituitary-thyroid axis in subjects with brain stroke

Internal Medicine

Volumn 32, Issue 9, 1993, Pages 681-685

  Miyashita, Kazuya ^a   Murakami, Masami ^a   Satoh, Tetsurou ^a   Monden, Tsuyoshi ^a   Yamada, Masanobu ^a   Iriuchijima, Tokuji ^a   Kazihara, Akio ^a   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

thyroid hormone; TRH; TRH analog; TRH test; TSH

Indexed keywords

PROTIRELIN; TALTIRELIN; THYROID HORMONE; THYROTROPIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPOPHYSIS THYROID SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; STROKE;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; CEREBROVASCULAR DISORDERS; FEMALE; FOLLICLE STIMULATING HORMONE; GROWTH HORMONE; HUMAN; LUTEINIZING HORMONE; MALE; MIDDLE AGE; PITUITARY GLAND; PROLACTIN; PROTIRELIN; THYROID GLAND; THYROTROPIN;

EID: 0027768572     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.32.681     Document Type: Article

References (15)

1. Prasad C. Thyrotropin-releasing hormone, in: Handbook of Neurochemistry, Vol 8, 1984, p. 175.
2. Brooks BR. A summary of the current position of TRH in ALS therapy. Ann N Y Acad Sci 553: 431, 1989.
3. Gradley WG. Critical review of gangliosides and thyrotropin-releasing hormone in peripheral neuromuscular diseases. Muscle Nerv 13: 833, 1990.
4. Guiloff RJ. Use of TRH analogues in motor neuron disease. Ann N Y Acad Sci 553: 399, 1989.
5. Yamamura M, Kinoshita K, Nakagawa H, Tanaka T, Maeda K, Ishida R. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog, (I): effects on the central nervous system by oral administration. Jpn J Pharmacol 53: 451, 1990.
6. Yamamura M, Kinoshita K, Nakagawa H, Ishida R. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (II): involvement of the DA system in the locomotor stimulating action of TA-0910. Jpn J Pharmacol 55: 57, 1991.
7. Yamamura M, Kinoshita K, Nakagawa H, Ishida R. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (IV): effects on experimental memory impairment in mice and rats. Jpn J Pharmacol 55: 241, 1991.
8. Frey HM, Haug E. Effect of prolonged oral administration of TRH on plasma levels of thyrotrophin and prolactin in normal individuals and in patients with primary hypothyroidism. Acta Endocrinol 85: 744, 1977.
9. Staub JJ, Girard J, Mueller-Braud J, et al. Blunting of TSH response after repeated oral administration of TRH in normal and hypothyroid subjects. J Clin Endocrinol Metab 46: 260, 1978.
10. Mitsuma T. Changes in endocrinological functions after three-week oral administration of TRH-T in patients with spinal cerebellar ataxia. Shinyaku to Rinsyou 34: 68, 1985 (in Japanese).
11. Suzuki M, Sugano H, Matsumoto K, Yamamura M, Ishida R. Synthesis and central nervous system actions of thyrotropin-releasing hormone analogues containing a dihydroorotic acid moiety. J Med Chem 33: 2130, 1990.
12. Furuuchi S, Takahashi M, Tushima S, Furukawa M, Takaichi Y. Estimation of TA-0910 by immunofluoro-HPLC method. Proceeding of the Pharmaceutical Society Japan, Tokyo #I-120, 1991 (abstract).
13. Mori M, Yamada M, Kobayashi S. Role of the hypothalamic TRH in the regulation of its own receptors in rat anterior pituitaries. Neuroendocrinology 48: 153, 1988.
14. Yamada M, Mori M. Thyrotropin-releasing hormone-degrading enzyme in human serum is classified as type II of pyroglutamyl aminopeptidase: influence of thyroid status. Proc Soc Exp Biol Med 194: 346, 1990.
15. Yanagimoto S, Takayanagi T, Tamura R, et al. Clinical evaluation of TA-0910 in the treatment of spinocerebellar degeneration. Shinkeinaikachiryou 8: 311, 1991 (in Japanese).